Avita Medical | 1811094D - EPS每股收益



金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 401.61M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


Eps 更改 日
Accuray USD 0.02 0.06 2024-12
Celltrion KRW 1.35K 224.25 2026-06
Clinuvel Pharmaceuticals AUD 0.21 0.23 2025-12
Cochlear AUD 3.13 0.25 2025-12
CSL USD 5.07 3 2025-12
Cspc Pharmaceutical CNY 0.08 0.08 2026-03
Deva Holding AS TRY 2.92 1.6 2023-09
Dianthus Therapeutics USD -0.85 0.58 2026-03
Divis Laboratories Ltd INR 24.02 4.27 2026-06
Kangmei Pharma CNY 0 0 2026-03
Knight Therapeutics CAD 0.13 0.22 2026-03
Laboratorios Farma EUR 1.96 0.71 2023-12
Malin Corporation EUR -0.06 0.1 2023-12
Mayne Pharma AUD 0.31 0.46 2026-06
Medical Developments International AUD 0 0 2025-12
Nanosonics AUD 0.03 0.01 2025-12
Neuren Pharmaceuticals AUD 0.12 0.06 2025-12
Organigram Holdings CAD -0.01 0.15 2026-03
Ovoca Bio EUR 0 0.06 2025-12
Pacific Edge NZD -0.02 0.01 2026-06
Paradigm Biopharmaceuticals AUD -0.06 0.03 2025-12
Pharma Mar EUR 0.16 0.07 2026-06
Polynovo AUD 0.01 0 2026-06
PYC Therapeutics AUD -0.04 0.01 2025-12
Qiagen NV USD 0.54 0.08 2026-06
Ramsay Health Care AUD 0.7 0.04 2026-12
ResMed USD 0.27 2.41 2026-03
Sartorius EUR 0.95 0.25 2026-06
Sino Biopharmaceutical CNY 0.19 0.25 2026-06
Telix Pharmaceuticals AUD 0.1 0.16 2026-06
Tilray USD -0.41 0.4 2025-12
Zealand Pharma A/S -5.58 2.76 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 0.97 0.27 2026-06